CORAL DRUGS PVT LTD

Overview

CORAL DRUGS PVT LTD is an active pharmaceutical ingredient (API) supplier with 15 active FDA Type II Drug Master Files, covering AZELASTINE HYDROCHLORIDE USP; BUDESONIDE; CICLESONIDE; DEFLAZACORT; EXEMESTANE; FLUTICASONE FUROATE.

API / Drug Master Files

CORAL DRUGS PVT LTD holds 15 active (15 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DEFLAZACORTActive2023-10-05
• CICLESONIDEActive2023-04-08
• EXEMESTANEActive2023-03-29
• TRIAMCINOLONE HEXACETONIDEActive2022-08-04
• FLUTICASONE PROPIONATE (PROCESS 1)Active2021-11-18
• FLUTICASONE FUROATE (PROCESS 1)Active2021-10-22
• AZELASTINE HYDROCHLORIDE USPActive2021-10-09
• MOMETASONE FUROATE USP (PROCESS I)Active2021-07-14
• FLUTICASONE FUROATEActive2017-10-02
• TRIAMCINOLONE ACETONIDEActive2017-02-06
• BUDESONIDEActive2017-02-02
• MOMETASONE FUROATE MONOHYDRATEActive2016-11-25
• MOMETASONE FUROATEActive2016-09-09
• FORMOTEROL FUMARATE DIHYDRATEActive2016-06-04
• FLUTICASONE PROPIONATEActive2008-08-12

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CORAL DRUGS PVT LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.